These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10880524)

  • 1. H2-DMalpha(-/-) mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection.
    Felix NJ; Brickey WJ; Griffiths R; Zhang J; Van Kaer L; Coffman T; Ting JP
    J Exp Med; 2000 Jul; 192(1):31-40. PubMed ID: 10880524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
    Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
    Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged survival of class II transactivator-deficient cardiac allografts.
    June Brickey W; Felix NJ; Griffiths R; Zhang J; Wang B; Piskurich JF; Itoh-Lindstrom Y; Coffman TM; Ting JP
    Transplantation; 2002 Nov; 74(9):1341-8. PubMed ID: 12451276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes.
    Osawa H; Streilein JW
    Cornea; 2005 Apr; 24(3):312-8. PubMed ID: 15778605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
    Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
    Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants.
    Fedoseyeva EV; Kishimoto K; Rolls HK; Illigens BM; Dong VM; Valujskikh A; Heeger PS; Sayegh MH; Benichou G
    J Immunol; 2002 Aug; 169(3):1168-74. PubMed ID: 12133936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.
    Pêche H; van Denderen B; Roussel JC; Trinité B; Soulillou JP; Cuturi MC
    Transplantation; 2004 Mar; 77(5):733-40. PubMed ID: 15021837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants.
    Illigens BM; Yamada A; Anosova N; Dong VM; Sayegh MH; Benichou G
    Eur J Immunol; 2009 Nov; 39(11):3000-9. PubMed ID: 19658090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchical contributions of allorecognition pathways in chronic lung rejection.
    Chalermskulrat W; Neuringer IP; Brickey WJ; Felix NJ; Randell SH; Ting JP; Aris RM
    Am J Respir Crit Care Med; 2003 Apr; 167(7):999-1007. PubMed ID: 12446274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses.
    Li XC; Zand MS; Li Y; Zheng XX; Strom TB
    J Immunol; 1998 Sep; 161(5):2241-7. PubMed ID: 9725217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical, invariant chain-independent role for H2-M in antigen presentation.
    Swier K; Brown DR; Bird JJ; Martin WD; Van Kaer L; Reiner SL
    J Immunol; 1998 Jan; 160(2):540-4. PubMed ID: 9551884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional role of class II-associated invariant chain peptide (CLIP) in its ability to variably modulate immune responses.
    Chaturvedi P; Hengeveld R; Zechel MA; Lee-Chan E; Singh B
    Int Immunol; 2000 Jun; 12(6):757-65. PubMed ID: 10837403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
    Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
    J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of major histocompatibility complex in type 1 diabetes recurrence after islet transplantation.
    Young HY; Zucker P; Flavell RA; Jevnikar AM; Singh B
    Transplantation; 2004 Aug; 78(4):509-15. PubMed ID: 15446308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.
    Shenoy S; Desch K; Duffy B; Thorson P; Mohanakumar T
    Clin Exp Immunol; 1998 May; 112(2):188-95. PubMed ID: 9649180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts.
    Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM
    Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.